Pediatrics

10 Active
56 Finished

10 results

Filter

Active

Phase III, Randomized, Observer-Blind, Multicenter, Noninferiority Study to Evaluate Safety and Immunogenicity of Seqirus¿ Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and a US-licensed QIV in Healthy Subjects aged 6 Months through 47 Months
Fling, J.
Syneos Health
1/08/19 → 31/12/20
Project: Research
Healthy Start Eliminating Disparities in Perinatal Health
Raines-Milenkov, A. & Felini, M.
Health Resources & Service Administratio
1/04/19 → 31/03/24
Project: Research
¿A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study-Assess Safety/Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine-Administered Concomitantly with Routine Vaccines to Healthy Infants.
Fling, J.
GlaxoSmithKline
6/01/19 → 5/06/23
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
Basha, R. & Prokai, L.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
Basha, R. & Prokai, L.
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
Immunogenicity, reactogenicity and safety study of Pediarix, Hiberix and Prevenar 13 co-administered with two different formulations of GSK Biologicals' HRV vaccine (444563) in healthy infants 6-12 weeks of age.
Fling, J.
GlaxoSmithKline
7/07/17 → 6/07/21
Project: Research
A PHASE 3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER
Fling, J.
Pfizer, Inc.
13/04/17 → 13/04/21
Project: Research
A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
Fling, J.
MedImmune, LLC
8/11/16 → 7/11/21
Project: Research
Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Fling, J.
Sanofi Pasteur, Inc.
5/08/16 → 4/08/21
Project: Research
"Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years"
Fling, J.
Sanofi Pasteur, Inc.
10/06/16 → 10/06/21
Project: Research